Popular Articles

Therapeutic Contact Lenses And Patients' Own Stem Cells Used To Rehabilitate Damaged Eye Surfaces
In a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.

Obama Urges Swift Confirmation Of Sotomayor; GOP Mulls Opposition Strategy
President Obama on Tuesday in his official announcement of his nomination of Judge Sonia Sotomayor of the Second Circuit Court of Appeals to the Supreme Court emphasized what he called her "extraordinary journey" from a modest background to the top of the judiciary, launching a "confirmation battle that he hopes to wage over biography more than ideology," the New York Times reports. If confirmed, Sotomayor would be the first Hispanic and the third woman to serve on the court, as well as the sixth of the court"s current members with a Roman Catholic background, the Times reports (Baker/Zeleny, New York Times, 5/27). Sotomayor would replace retiring Justice David Souter, who typically is a liberal vote on social issues, the Wall Street Journal reports. Therefore, the addition of Sotomayor would not likely change the ideological balance of the court (Bravin/Koppel, Wall Street Journal, 5/27). The Washington Post reports Obama in his remarks cast Sotomayor "as the embodiment of the qualities he seeks in a judge," including superior intelligence, an understanding of the limited role of the judiciary and what he called "an understanding of how the world works and how ordinary people live" (Barnes/Fletcher, Washington Post, 5/27). The president said he wants Sotomayor to be confirmed before the Senate leaves in August for its summer recess, so she can join the court in time for its September review of potential cases. White House Press Secretary Robert Gibbs said that the Senate has "ample time" to complete the confirmation process, as the average time span is 72 days and there are 74 until the recess (Koffler, Roll Call, 5/26). Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) praised Obama"s decision, calling Sotomayor"s record "exemplary" and her nomination "historic." Leahy noted that both former President George H.W. Bush and former President Clinton nominated Sotomayor to federal judgeships, adding, "She has been nominated by both Democratic and Republican presidents, and she was twice confirmed by the Senate with strong, bipartisan support" (Stanton, Roll Call, 5/26).Rulings on Abortion Rights Throughout her career as a federal judge, Sotomayor has not issued what are considered major decisions regarding abortion rights, although her record on cases involving civil and social rights issues appear "more liberal than not," according to the New York Times (Liptak, New York Times, 5/27). Politico reports that Sotomayor has ruled in favor of antiabortion-rights groups in two cases. The first case occurred in 2002 when she sided with the Bush administration in its efforts to implement the "global gag rule," which banned federal funding for international family planning groups that offer abortion services or information with their own funds. Sotomayor ruled that the government had the right to decide how to spend its funding. In 2004, Sotomayor ruled in favor of antiabortion-rights protesters who alleged that they were brutalized while being arrested in West Hartford, Conn. (Gerstein/Javers, Politico, 5/26). Gibbs said that Obama did not ask Sotomayor about issues related to abortion during her vetting and there was "no litmus test" on abortion-rights issues (Koffler, Roll Call, 5/26).Obama"s announcement was well-received by many groups that support abortion rights. NARAL Pro-Choice America President Nancy Keenan said the group is anticipating more information about Sotomayor"s views on abortion rights and the right to privacy. She added that the group is "encouraged by the strong support she receives from her peers and other legal scholars and the fact that the Senate has twice confirmed her for federal judgeships" (Posner, Congress Daily, 5/26). Kim Gandy, president of the National Organization of Women, said that Sotomayor "brings a lifelong commitment to equality, justice and opportunity, as well as the respect of her peers, unassailable integrity and a keen intellect informed by experience." Gandy added that Obama "said he wanted a justice with "towering intellect" and a "common to
News of the day
REMERON(R) Now Approved In Japan For The Treatment Of Depression In Adult Patients
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company"s country operation in Japan, has received marketing approval for REMERON(R) /Reflex(R) (mirtazapine)15 mg Tablets for the treatment of major depressive disorder.(1) The product was developed jointly with Meiji Seika Kabushiki Kaisha, Ltd. Schering-Plough and Meiji Seika will market the product under the trade names, REMERON(R) and Reflex(R), respectively. REMERON is currently available in more than 90 countries worldwide.
Mental Health

Palliative Care Research To Benefit From $1.5 Million Award

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $1.5 million in research grants to researchers at eleven institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers. The studies will be conducted over the next two years. The NPCRC, in collaboration with the American Cancer Society, has directed over $5 million towards supporting 38 palliative care research projects since starting this initiative three years ago. "The physical and emotional symptoms that accompany chronic and serious illness like cancer cause so much suffering and yet have rarely been the focus of medical research or research funding" noted NPCRC Director R. Sean Morrison, M.D., who is also professor of Palliative Care, Geriatrics and Medicine at Mount Sinai School of Medicine. "It is my belief that if we are truly going to improve the quality of life for adults and children with chronic illness, then we need to focus our energies equally on disease specific treatments and on the physical, psychological, and emotional symptoms that accompany chronic illness and cause so much distress and suffering. Supporting evidenced-based research is a critical first step in the right direction," he noted. Palliative care focuses on relieving suffering and supporting the best possible quality of life for adults and children living with serious illness. It is a field comprised of doctors, nurses, social workers, and other specialists who care for patients with chronic illnesses, functional impairment, and a high burden of family caregiving responsibilities. It is provided at the same time as all other appropriate medical treatments. The collaborative initiative between the American Cancer Society and the National Palliative Care Research Center is designed to support clinician investigators conducting patient-oriented research in palliative care in hopes of bringing more funding from federal agencies, which have supported some research in palliative care, but for whom it is not a priority area. Pilot data results are typically needed before a federal agency will consider funding a research project. "It is encouraging to see the high caliber and innovative applications being submitted by professionals interested in conducting research in palliative care," said Ronit Elk, Ph.D., cancer control and prevention research program director in the extramural grants of the American Cancer Society. "This request for application (RFA) provides clinicians and researchers an opportunity to answer important questions they had long wanted to investigate, but without this unique funding opportunity had been unable to." "The American Cancer Society, in its initiative with the NPCRC, is making significant contributions towards reducing suffering caused by cancer and other serious illnesses," said Otis W. Brawley, M.D., chief medical officer of the American Cancer Society. "We strongly encourage other disease-specific organizations to follow suit and designate research dollars to further support research scientists who will advance the field of palliative care." The 2009 Grantees: NPCRC Pilot Project Support Grant Recipients Harvard Medical School - Jennifer W. Mack, M.D., MPH, an assistant professor of pediatrics at Dana-Farber Cancer Institute /Children"s Hospital Boston, will examine the interplay between hope, prognosis communication, and end-of-life decision-making in the pediatric oncology setting to find ways to improve how physicians communicate prognosis and support parents" hopes for their child"s end-of-life period. Ultimately, this work will help parents of children with advanced cancer make meaningful, value-driven decisions for their children"s lives and care. Northeastern Ohio Universities College of Medicine - Kyle R. Allen, D.O., professor of internal medicine and family medicine, and chief of the division of geriatric medicine and medical director of the Post Acute Senior Services Service Line at Summa Health System in Akron, Ohio, will conduct a randomized pilot study along with his co-investigator, Steven Radwany, M.D., medical director of hospice and palliative care at Summa Health System to determine the feasibility of a fully powered study to test the effectiveness of an in-home interdisciplinary palliative care case management intervention in improving a global measure of quality palliative care for consumers of Ohio"s community-based long-term care Medicaid waiver program, PASSPORT. American Cancer Society Pilot Project Support Grant Recipients University of North Carolina, Chapel Hill - Edwin B. Fisher, Ph.D., a professor in the department of health behavior and health education in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. Dr. Fisher"s research will describe how different types of support, including nondirective (cooperative) and directive (prescriptive) support may play key roles in quality of life among patients with advanced cancer or who are receiving palliative care. This will also lead to research to develop interventions that will improve quality of life for patients with advanced cancer and to develop guides or other res that will help their friends, family, and clinical teams to be more effective in providing them social support. University of Oklahoma Health Sciences Center - Marianne Matzo, Ph.D., a professor and the Frances E. and A. Earl Ziegler Chair in Palliative Care Nursing at The University of Oklahoma Health Sciences Center College of Nursing in Oklahoma City, Oklahoma, will focus on developing and pilot testing a coached communication intervention for sexual health promotion in women with recurring ovarian cancer (OVCA). This is a significant research area because it is an important concern of hospice patients which has not been well studied. This study will pave the way toward a larger, interventional study of palliative care patients and their sexual health. University of California, San Francisco - Michael Rabow, M.D., an associate professor of clinical medicine in the division of general internal medicine at the University of California, San Francisco, will evaluate the clinical efficacy, family caregiver outcomes, and health care utilization impacts of a surgical oncologic/palliative care co-management model for patients with bladder cancer to determine an intervention able to decrease suffering and improve well-being among bladder cancer patients and families. Elucidating the benefits of concurrent disease and symptom care may provide an innovative model that is broadly useful in the outpatient care of patients with other life-threatening cancers. Harvard Medical School - Jennifer Temel, M.D., an assistant professor of medicine at Harvard Medical School and an attending physician in thoracic oncology at Massachusetts General Hospital, will conduct a study to encourage oncology clinicians to discuss and document their patient"s goals of care and end-of-life care wishes. The intervention will involve an electronic reminder, sent via email, which contains pertinent information about the patients" disease and prognosis and res to assist the clinician with the conversation. Northwestern University, Feinberg School of Medicine - Jamie H. Von Roenn, M.D., a professor of medicine at Northwestern University, Feinberg School of Medicine, is a medical oncologist and expert in palliative medicine. She is Medical Director of the Palliative Care and Home Hospice Program at Northwestern Memorial Hospital and a full member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, will conduct a randomized study to examine the effects of a tailored physical therapy program on patients with advanced cancer newly hospitalized on the inpatient oncology unit for acute care. Such rehabilitation might maintain or improve these patients" physical function, compared to patients who receive the usual care. NPCRC Junior Faculty Career Development Award Recipients Harvard Medical School - Jane L. Givens, M.D., MCSE, an instructor of medicine within the division of gerontology at Beth Israel Deaconess Medical Center and Hebrew SeniorLife Institute for Aging Research will conduct one of the first detailed studies of family members of nursing home residents with advanced dementia to promote understanding of the mental health burdens facing over 4 million US families whose loved ones are experiencing the end-stage of dementia in nursing homes, and set the foundation for future research aimed at developing strategies to lessen that burden. Brown University - Ramona Rhodes, M.D., MPH, an assistant professor of medicine within the division of geriatrics at Lifespan/Rhode Island Hospital, Alpert Medical School, Brown University will conduct a study to improve hospice care for minorities. Specifically, she will describe and examine hospice-level variability associated with African Americans" perceptions of the quality of hospice services as well as identify processes of care and interventions that have resulted in improved quality of care for African Americans, through a nationwide survey of hospice providers. San Diego Hospice and Palliative Care - Scott A. Irwin, M.D., Ph.D., is an assistant clinical professor of psychiatry at University of California, San Diego, a diplomate of the American Board of Psychiatry and Neurology and is the Director of Psychiatry Programs at the Institute for Palliative Medicine at San Diego Hospice. Dr. Irwin will assess the feasibility of conducting a randomized, controlled, safety and efficacy trial of rapidly treating major depressive episodes with methylphenidate monotherapy in patients receiving hospice care. This trial will lay the groundwork for future multi-site randomized controlled trials in patients receiving hospice care and their caregivers, which are lacking for many psychiatric interventions used in this population. University

Pages: [1] 2 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):